キュキュルビタシンBの抗がん剤としての最近の進歩
Dongge Yin1, Hongyue Chen1, Shuting Lin1
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
International journal of molecular sciences
|August 28, 2025
まとめ
植物由来化合物であるキュルビタシンBは,細胞死を誘発し,腫瘍の成長を抑制することによって,広範囲の抗癌作用を示します. 研究は,がん治療の改善のための改変と配信システムを介してその可能性を高めることを探しています.
科学分野:
- 自然製品化学
- 薬理学について
- 腫瘍学
背景:
- クキュルビタシンB (CuB) は,クキュルビタセア植物からのテトラサイクルトリテルペノイドであり,肝臓疾患の補助療法に歴史的に使用されています.
- CuBは,肝臓,胃,直腸を含む様々な癌細胞に対する抑制効果を示しています.
- 1970年代から1980年代にかけてその抗がん作用が認められてきた.
研究 の 目的:
- キュルビタシンBの物理化学的特性,抗癌メカニズム,および適用戦略を体系的に検討する.
- キュルビタシンBの科学研究と臨床翻訳における将来の研究方向性を特定する.
- 癌治療におけるCuBの潜在的可能性の包括的な概要を提供する.
主な方法:
- クキュルビタシンBに関する既存の研究を要約した文献レビュー.
- アポプトーシス,細胞サイクル停止,オートファギー,および抗血管新生を含むCuBの複数の抗癌メカニズムの分析.
- JAK/STAT,PI3K/Akt/mTORなどのCuBの影響に関わるシグナル伝達経路の検討
主要な成果:
- CuBは,アポトーシス誘発,細胞循環停止,そして移転と血管新生を阻害するなどの多様なメカニズムを通じて,広範囲の抗がん活性を示しています.
- CuBによって調節される主要な経路には,JAK/STAT,PI3K/Akt/mTOR,およびFOXM1-KIF20Aが含まれています.
- 構造改変,組み合わせ療法,ナノマテリアル投与などの戦略はCuBの有効性と生物利用性を高めます.
結論:
- クキュルビタシンBは,複数の作用メカニズムで,重要な抗がん性を持っています.
- 細胞特異的な感受性と免疫系相互作用を明らかにするためにさらなる研究が必要である.
- クリニックでの CuB の進歩には最適化された応用戦略が不可欠です.
さらに関連する動画
06:39Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.1K
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.1K
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
